Share Us: Email Icon Facebook icon Twitter Icon GooglePlus Icon Facebook Like icon   Subscribe | Contact

User Top Menu

Latest News

28 July 2015

Coffee Consumption Habits Impact the Risk of Mild Cognitive Impairment: The Italian Longitudinal Study on Aging

A new study estimates the association between change or constant habits in coffee consumption and the incidence of mild cognitive impairment, evaluating 1,445 individuals recruited from 5,632 subjects, aged 65-84 year old, from the Italian Longitudinal Study on Aging, a population-based sample from eight Italian municipalities with a 3.5-year median follow-up.

14 July 2015

Affordable, Non-Invasive Test May Detect Who is Most at Risk for Alzheimer's

Photo caption:  Dr. John Hart Jr. (left) and Dr. Hsueh-Sheng Chiang (right), with researchers Drs. Jeremy Strain and Neena Rao, led the study on a new non-invasive test for Alzheimer's disease.

Individuals with amnestic mild cognitive impairment (aMCI) are at twice the risk of others in their age group of progressing to Alzheimer’s disease. Although no conclusive test exists to predict who will develop Alzheimer’s, new research from the Center for BrainHealth at The University of Texas at Dallas is attempting to identify a potential biomarker that could offer a more complete picture of who is most at risk.

26 June 2015

Hartmuth Kolb, PhD, Wins 2015 Alzheimer Award

Hartmuth Kolb

The Journal of Alzheimer’s Disease is proud to announce that Hartmuth Kolb, PhD, Head of Neuroscience Biomarkers, Johnson & Johnson, San Diego, CA, has been chosen as the recipient of the 2015 Alzheimer Award presented by the Journal of Alzheimer’s Disease in recognition of his outstanding work on the importance and imaging of neurofibrillary tangles and Alzheimer’s disease.

24 June 2015

Multiple Pathways Progressing to Alzheimer’s Disease

The amyloid cascade hypothesis of Alzheimer’s disease (AD) posits that sticky aggregations or plaques of amyloid-beta peptides accumulate over time in the brain, triggering a series of events that ultimately result in the full-blown neurodegenerative disorder. However, in a new study published in JAD, researchers at University of California, San Diego School of Medicine and Veterans Affairs San Diego Healthcare System suggest the picture is not so clear-cut, reporting that early indicators or biomarkers of AD development are not fixed in a specific sequence.

10 June 2015

Anti-rejection medications for transplant recipients protect against Alzheimer’s disease

Luca Cicalese and Giulio Taglialatela

A new study from The University of Texas Medical Branch at Galveston has revealed that a treatment taken daily by people who have had organ transplants to prevent organ rejection protects against Alzheimer’s disease. An early online version of this paper detailing the findings has been published and is scheduled for publication in the July 7 issue of the Journal of Alzheimer’s Disease.

25 May 2015

Dementia found to decrease sexual activity

Dr Rebekah Ahmed

In a new study published in the Journal of Alzheimer’s Disease, Dr Rebekah Ahmed and colleagues found that patients with dementia show a decrease in sexual relations with their partners. The study, led by NeuRA’s Prof John Hodges focused specifically on patients with frontotemporal dementia, the second most common cause of young-onset dementia (aged less than 65 years), which is typically associated with changes in behaviour and personality.

5 May 2015

Green Tea Extract and Exercise Hinder Progress of Alzheimer's Disease in Mice

According to the National Institutes of Health (NIH), Alzheimer’s disease (AD) may affect as many as 5.5 million Americans. Scientists currently are seeking treatments and therapies found in common foods that will help stave off the disease or prevent it completely. Now, University of Missouri researchers have determined that a compound found in green tea, and voluntary exercise, slows the progression of the disease in mice and may reverse its effects.


Subscribe to Latest News